Atlas Trials

Pharmacokinetics, Efficacy and Safety of the 304 Injection

Clinical trial NCT03980379 · UNKNOWN

Trial details

NCT number
NCT03980379
Sponsor
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
CD20 Positive B Cell NHL
Start date
2018-12-18
Primary completion
2019-06-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.